EGFR-IN-139
EGFR-IN-139 (compound PD 18) is an epidermal growth factor receptor (EGFR) inhibitor, with IC50s of 12.88 (wild type), 10.84 (L858R/T790M), 42.68 (L858R/T790M/C797S) nM, respectively. EGFR-IN-139 displays strong anticancer activity against A549 and H1975 cancer cell lines, which are highly expressed EGFR. EGFR-IN-139 has a strong selectivity to cancer cells. EGFR-IN-139 can be used for nonsmall cell lung cancer (NSCLC) research[1].
For research use only. We do not sell to patients.
- CAS No.: 1574321-31-5
- Formula: C27H25ClN2O4
- Molecular Weight:476.95
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
EGFR-IN-139 (1 μM, 2 h) inhibits wild-type EGFR and L858R/T790M EGFR with inhibition rates of 90-100% and 65-75% , respectively[1].
EGFR-IN-139 (0-100 μM, 72 h) inhibits A549, H1975, Vero cells with IC50 s of 28.23 , 29.46, 180.9 μM, respectively[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549, H1975 cells
-
Concentration:0-100 μM
-
Incubation Time:72 h
-
Result:Inhibited A549, H1975, Vero cells with IC50s of 28.23 (similar to that of Erlotinib (HY-50896)), 29.46, 180.9 μM,.
Was relatively safe for normal cells, as its IC50 value in Vero cells was higher compared to those in A549 (SI(IC50 of A549 and H1975) versus IC50 of Vero) of 6.40) and H1975 (SI of 6.14).
Chemical Information
-
CAS No. 1574321-31-5
-
Molecular Weight 476.95
-
Formula C27H25ClN2O4
-
SMILES
O=C(C1=CC=C2OCCOC2=C1)C(O3)=CC4=C3C(C)=NC=C4CN5CC6=C(C=CC=C6)CC5.Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)